These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31103898)
1. Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities. Fei BL; Tu S; Wei Z; Wang P; Qiao C; Chen ZF Eur J Med Chem; 2019 Aug; 176():175-186. PubMed ID: 31103898 [TBL] [Abstract][Full Text] [Related]
2. Copper(II) and iron(III) complexes of chiral dehydroabietic acid derived from natural rosin: metal effect on structure and cytotoxicity. Fei BL; Hui CN; Wei Z; Kong LY; Long JY; Qiao C; Chen ZF Metallomics; 2021 Apr; 13(4):. PubMed ID: 33765148 [TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of optically pure chiral binuclear copper(ii) complexes based on a rosin derivative as highly potential anticancer agents. Fei BL; Tu S; Wei Z; Wang P; Long JY; Qiao C; Chen ZF Dalton Trans; 2019 Oct; 48(41):15646-15656. PubMed ID: 31465061 [TBL] [Abstract][Full Text] [Related]
4. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention. Khan S; Zafar A; Naseem I Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612 [TBL] [Abstract][Full Text] [Related]
5. Enantiopure copper(II) complex of natural product rosin derivative: DNA binding, DNA cleavage and cytotoxicity. Fei BL; Yin B; Li DD; Xu WS; Lu Y J Biol Inorg Chem; 2016 Dec; 21(8):987-996. PubMed ID: 27628182 [TBL] [Abstract][Full Text] [Related]
6. Hypotoxic copper complexes with potent anti-metastatic and anti-angiogenic activities against cancer cells. Shi X; Chen Z; Wang Y; Guo Z; Wang X Dalton Trans; 2018 Apr; 47(14):5049-5054. PubMed ID: 29561011 [TBL] [Abstract][Full Text] [Related]
7. Antitumoral and Antimetastatic Activity by Mixed Chelate Copper(II) Compounds (Casiopeínas González-Ballesteros MM; Sánchez-Sánchez L; Espinoza-Guillén A; Espinal-Enríquez J; Mejía C; Hernández-Lemus E; Ruiz-Azuara L Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201489 [TBL] [Abstract][Full Text] [Related]
8. Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer. Jiang M; Yan Q; Fu Y; Meng L; Gai S; Pan X; Qin Y; Jiang C J Inorg Biochem; 2024 Jul; 256():112550. PubMed ID: 38599004 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction. Wang H; Wei J; Jiang H; Zhang Y; Jiang C; Ma X Molecules; 2021 Mar; 26(5):. PubMed ID: 33800091 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers. Nagababu P; Barui AK; Thulasiram B; Devi CS; Satyanarayana S; Patra CR; Sreedhar B J Med Chem; 2015 Jul; 58(13):5226-41. PubMed ID: 26068145 [TBL] [Abstract][Full Text] [Related]
12. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase. Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH). Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543 [TBL] [Abstract][Full Text] [Related]
14. Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity. Qin XY; Liu YN; Yu QQ; Yang LC; Liu Y; Zhou YH; Liu J ChemMedChem; 2014 Aug; 9(8):1665-71. PubMed ID: 24839939 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and multiple targeting with selectivity: Anticancer property of ternary metal phenanthroline-maltol complexes. Ng CH; Tan TH; Tioh NH; Seng HL; Ahmad M; Ng SW; Gan WK; Low ML; Lai JW; Zulkefeli M J Inorg Biochem; 2021 Jul; 220():111453. PubMed ID: 33895694 [TBL] [Abstract][Full Text] [Related]
16. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate. Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073 [TBL] [Abstract][Full Text] [Related]
17. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents. Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010 [TBL] [Abstract][Full Text] [Related]
18. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity. Zafar A; Singh S; Naseem I J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors. Fernandes C; Horn A; Lopes BF; Bull ES; Azeredo NFB; Kanashiro MM; Borges FV; Bortoluzzi AJ; Szpoganicz B; Pires AB; Franco RWA; Almeida JCA; Maciel LLF; Resende JALC; Schenk G J Inorg Biochem; 2015 Dec; 153():68-87. PubMed ID: 26485179 [TBL] [Abstract][Full Text] [Related]
20. Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer. Gou Y; Chen M; Li S; Deng J; Li J; Fang G; Yang F; Huang G J Med Chem; 2021 May; 64(9):5485-5499. PubMed ID: 33861929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]